Raungrut P, Jirapongsak J, Tanyapattrapong S, Bunsong T, Ruklert T, Kueakool K
Int J Mol Sci. 2025; 26(3).
PMID: 39940778
PMC: 11817752.
DOI: 10.3390/ijms26031010.
Habu T, Yamamoto H, Nakata K, Hashimoto K, Tanaka S, Shien K
Surg Today. 2024; 55(3):405-413.
PMID: 39196340
PMC: 11842485.
DOI: 10.1007/s00595-024-02927-6.
He J, Li F, Jing Z, Ren X, Jia D, Zeng Y
Biomedicines. 2024; 12(7).
PMID: 39062049
PMC: 11274686.
DOI: 10.3390/biomedicines12071477.
De Wilt L, Sobocki B, Jansen G, Tabeian H, de Jong S, Peters G
Cancer Drug Resist. 2024; 7:12.
PMID: 38835345
PMC: 11149110.
DOI: 10.20517/cdr.2024.14.
Raungrut P, Tanyapattrapong S, Jirapongsak J, Geater S, Thongsuksai P
Asian Pac J Cancer Prev. 2023; 24(9):3003-3013.
PMID: 37774051
PMC: 10762756.
DOI: 10.31557/APJCP.2023.24.9.3003.
Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients.
Lei X, Li T, Mao F, Ren F, Tang Q, Cao W
Cancer Med. 2023; 12(16):16896-16905.
PMID: 37403701
PMC: 10501251.
DOI: 10.1002/cam4.6319.
Descriptive Analysis of First-Line Non-Small Cell Lung Cancer Treatment with Pembrolizumab in Tumors Expressing PD-L1 ≥ 50% in Patients Treated in Quebec's University Teaching Hospitals (DALP-First Study).
Berard G, Guevremont C, Marcotte N, Schroeder C, Bouchard N, Rajan R
Curr Oncol. 2023; 30(3):3251-3262.
PMID: 36975460
PMC: 10047395.
DOI: 10.3390/curroncol30030247.
LncRNA ANRIL promotes HR repair through regulating PARP1 expression by sponging miR-7-5p in lung cancer.
Du Z, Zhang F, Liu L, Shen H, Liu T, Jin J
BMC Cancer. 2023; 23(1):130.
PMID: 36755223
PMC: 9906921.
DOI: 10.1186/s12885-023-10593-z.
Positron emission tomography - Computed tomography for staging of mediastinal lymph nodes in patients with non-small cell lung cancer.
Prisadov G, Blume-Vulin A, Scharpenberg M, Welcker K, Kesieme E, Linder A
Ann Afr Med. 2023; 22(1):101-106.
PMID: 36695230
PMC: 10064889.
DOI: 10.4103/aam.aam_12_22.
Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology.
de Marinis F, Attili I, Gridelli C, Cecere F, Curcio C, Facciolo F
Front Oncol. 2022; 12:971042.
PMID: 35936741
PMC: 9355696.
DOI: 10.3389/fonc.2022.971042.
Single B Cell Gene Co-Expression Networks Implicated in Prognosis, Proliferation, and Therapeutic Responses in Non-Small Cell Lung Cancer Bulk Tumors.
Ye Q, Guo N
Cancers (Basel). 2022; 14(13).
PMID: 35804895
PMC: 9265014.
DOI: 10.3390/cancers14133123.
The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.
de Jong C, Chargi N, Herder G, van Haarlem S, van der Meer F, van Lindert A
J Cachexia Sarcopenia Muscle. 2022; 13(3):1554-1564.
PMID: 35301821
PMC: 9178405.
DOI: 10.1002/jcsm.12967.
Factors Associated with Nodal Upstaging in Clinical T1a-bN0M0 Non-Small Cell Lung Cancers.
Tsai T, Liu C, Lin M, Hsu H, Chen J
Cancers (Basel). 2022; 14(5).
PMID: 35267588
PMC: 8909294.
DOI: 10.3390/cancers14051277.
Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung Irradiation.
Kocsis Z, Farkas G, Bajcsay A, Kun-Gazda M, Lovey J, Ostoros G
Front Oncol. 2022; 11:829972.
PMID: 35155217
PMC: 8828562.
DOI: 10.3389/fonc.2021.829972.
A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer.
Ye Q, Falatovich B, Singh S, Ivanov A, Eubank T, Guo N
Int J Mol Sci. 2022; 23(1).
PMID: 35008645
PMC: 8745553.
DOI: 10.3390/ijms23010219.
Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer.
Chen J, Huang M, Lee Y, Lin M, Yang Y
J Oncol. 2021; 2021:1901191.
PMID: 34868311
PMC: 8639264.
DOI: 10.1155/2021/1901191.
GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer.
Jeong H, Choi B, Park J, Jung J, Shin H, Kang K
Cancers (Basel). 2021; 13(21).
PMID: 34771645
PMC: 8582534.
DOI: 10.3390/cancers13215482.
PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancer.
Yu H, Chen P, Xia L, Fu S, Chen C, Zhang X
J Immunother Cancer. 2021; 9(11).
PMID: 34750245
PMC: 8576478.
DOI: 10.1136/jitc-2021-003431.
Contribution of Neuropilin-1 in Radiation-Survived Subclones of NSCLC Cell Line H1299.
Tsutsumi K, Chiba A, Tadaki Y, Minaki S, Ooshima T, Takahashi H
Curr Issues Mol Biol. 2021; 43(3):1203-1211.
PMID: 34698100
PMC: 8928997.
DOI: 10.3390/cimb43030085.
Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
Zhang Y, Yan S, Li Y, Zhang J, Luo Y, Li P
Mol Med Rep. 2021; 24(5).
PMID: 34505633
PMC: 8441965.
DOI: 10.3892/mmr.2021.12429.
